type here...

CATEGORIES

Healthcare

LATEST

1...636465...76Page 64 of 76

TRENDING

EDITORS CHOICE

Is the Covid Vaccine’s Spike Protein Killing Us?

Robert Turner, Founding Editor -
What are the clinical reasons these vaccines cause death in some people?

Fear and Uncertainty: A New Health Reality for Families

Cullen Burnell -
COVID, Flu, RSV and More – Parents and Providers are on the Frontlines of decision.

One Trick to Lowering Heart Risk: Friends Have Benefits

Michael Hunter, MD -
Cardiovascular disease is the number one cause of death among high-income countries and is projected to be the leading cause of death worldwide by 2030.

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

Medika Life -
The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories